Pegylated Interferon (PEG-Intron) for Chronic Hepatitis C
Recombinant interferon alfa-2b conjugated to polyethylene glycol (PEG-Intron), the first "pegylated"alpha interferon, has been approved by the FDA for once-a-week monotherapy of chronic hepatitis C virus (HCV) infection in patients not previously treated with alpha interferon....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Pegylated Interferon (PEG-Intron) for Chronic Hepatitis C
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1107
Article Code: 1107b
Date: June 25, 2001
Volume: 43
Pages: 54-55
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1107
Article Code: 1107b
Date: June 25, 2001
Volume: 43
Pages: 54-55
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)